HCW Biologics maintains momentum toward IND application completion
HCW Biologics said it is progressing toward completing its IND application for a clinical study evaluating its lead T-cell engager in solid tumors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
HCW Biologics maintains momentum toward completing IND application
HCW Biologics says it is maintaining momentum toward completion of an IND application for a clinical study to evaluate its lead T-cell engager in solid tumors.